{"id":815431,"date":"2025-02-20T07:23:49","date_gmt":"2025-02-20T12:23:49","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-fourth-quarter-2024-financial-results-release\/"},"modified":"2025-02-20T07:23:49","modified_gmt":"2025-02-20T12:23:49","slug":"evogene-schedules-fourth-quarter-2024-financial-results-release","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-fourth-quarter-2024-financial-results-release\/","title":{"rendered":"Evogene Schedules Fourth Quarter 2024 Financial Results Release"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <i>Zoom conference call scheduled for <span class=\"xn-chron\">March 6, 2025<\/span>, <span class=\"xn-chron\">9:00 AM ET<\/span><\/i>\n      <\/p>\n<p>\n        <span class=\"legendSpanClass\">REHOVOT, <span class=\"xn-location\">Israel<\/span><\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Feb. 20, 2025<\/span><\/span> \/PRNewswire\/ &#8212;\u00a0<b>Evogene Ltd<\/b>. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the fourth quarter of 2024, on <b><span class=\"xn-chron\">Thursday, March 6, 2025<\/span><\/b>.<\/p>\n<div id=\"prni_dvprnejpg563cleft\" dir=\"ltr\" style=\"width: 100%;text-align: left\">\n        <img decoding=\"async\" id=\"prnejpg563cleft\" title=\"Evogene-Logo\" src=\"http:\/\/mma.prnewswire.com\/media\/1947468\/4576969\/Evogene_Logo.jpg\" alt=\"Evogene-Logo\" align=\"middle\" data-name=\"url$http%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F1947468%2F4576969%2FEvogene_Logo.jpg\" \/>\n      <\/div>\n<p>Later that day, Company management will host a <b>conference call to discuss the results at <span class=\"xn-chron\">9:00 AM Eastern Time<\/span><\/b> (<span class=\"xn-chron\">4:00 PM<\/span> Israel time).<\/p>\n<p>To join the conference, please register in advance:<\/p>\n<p>\n        <a href=\"https:\/\/us06web.zoom.us\/webinar\/register\/WN_1cToyoipTfW8X0xtgEqPfw\" target=\"_blank\" rel=\"nofollow\">https:\/\/us06web.zoom.us\/webinar\/register\/WN_1cToyoipTfW8X0xtgEqPfw<\/a>\n      <\/p>\n<p>The entire conference will be available online on the company&#8217;s website a few days after.<\/p>\n<p>\n        <b>About Evogene:<\/b>\n      <\/p>\n<p>Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) is a computational biology company leveraging big data and artificial intelligence,\u00a0aiming to revolutionize the development of life-science-based products by utilizing cutting-edge technologies to increase the probability of success while reducing development time and cost.<\/p>\n<p>Evogene established three unique tech-engines &#8211; <i>MicroBoost<\/i><i>\u00a0AI<\/i>,\u00a0<i>ChemPass AI<\/i>\u00a0and\u00a0<i>GeneRator AI<\/i>. Each tech-engine\u00a0is focused on the discovery and development of products based on one of the following core components: microbes (<i>MicroBoost AI<\/i>), small molecules (<i>ChemPass AI<\/i>), and genetic elements (<i>GeneRator AI<\/i>).<\/p>\n<p>Evogene uses its tech-engines to develop products through strategic partnerships and collaborations, and its four subsidiaries including:<\/p>\n<ol type=\"1\">\n<li>\n          <b>Biomica Ltd.<\/b>\u00a0(<a href=\"http:\/\/www.biomicamed.com\/\" target=\"_blank\" rel=\"nofollow\">www.biomicamed.com<\/a>)\u00a0&#8211; developing and advancing novel microbiome-based therapeutics to treat human disorders powered by<i>\u00a0MicroBoost AI<\/i>;<\/li>\n<li>\n          <b><br \/>\n            <span class=\"xn-person\">Lavie Bio<\/span><br \/>\n          <\/b><br \/>\n          <b>Ltd.<\/b>\u00a0(<a href=\"http:\/\/www.lavie-bio.com\/\" target=\"_blank\" rel=\"nofollow\">www.lavie-bio.com<\/a>)<b> &#8211; <\/b>developing and commercially advancing, microbiome-based ag-biologicals powered by<i>\u00a0MicroBoost AI<\/i>;<\/li>\n<li>\n          <b>AgPlenus Ltd. <\/b>(<a href=\"http:\/\/www.agplenus.com\/\" target=\"_blank\" rel=\"nofollow\">www.agplenus.com<\/a>) &#8211; developing next-generation ag chemicals for effective and sustainable crop protection powered by<i>\u00a0ChemPass AI<\/i>;<\/li>\n<li>\n          <b>Casterra Ag <\/b><br \/>\n          <b>Ltd.<\/b>\u00a0(<a href=\"http:\/\/www.casterra.co\/\" target=\"_blank\" rel=\"nofollow\">www.casterra.co<\/a>) &#8211; developing and marketing superior castor seed varieties producing high yield and high-grade oil content on an industrial scale for the biofuel and other industries powered by<i>\u00a0GeneRator AI<\/i>.<\/li>\n<\/ol>\n<p>For more information, please visit: <a href=\"https:\/\/www.evogene.com\/\" target=\"_blank\" rel=\"nofollow\">www.evogene.com<\/a>.<\/p>\n<p>\n        <b>Contact<\/b>\n      <\/p>\n<p>\n        <a href=\"mailto:ir@evogene.com\" target=\"_blank\" rel=\"nofollow\">ir@evogene.com<\/a><br \/>\n        <br \/>Tel: +972-8-9311901<\/p>\n<p>Logo &#8211; <a href=\"https:\/\/mma.prnewswire.com\/media\/1947468\/4576969\/Evogene_Logo.jpg\" target=\"_blank\" rel=\"nofollow\">https:\/\/mma.prnewswire.com\/media\/1947468\/4576969\/Evogene_Logo.jpg<\/a><\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=LN22693&amp;sd=2025-02-20\" \/> View original content:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/evogene-schedules-fourth-quarter-2024-financial-results-release-302381283.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/evogene-schedules-fourth-quarter-2024-financial-results-release-302381283.html<\/a><\/p>\n<p>SOURCE  Evogene<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=LN22693&amp;Transmission_Id=202502200700PR_NEWS_USPR_____LN22693&amp;DateId=20250220\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire Zoom conference call scheduled for March 6, 2025, 9:00 AM ET REHOVOT, Israel, Feb. 20, 2025 \/PRNewswire\/ &#8212;\u00a0Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the fourth quarter of 2024, on Thursday, March 6, 2025. Later that day, Company management will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time). To join the conference, please register in advance: https:\/\/us06web.zoom.us\/webinar\/register\/WN_1cToyoipTfW8X0xtgEqPfw The entire conference will be available online on the company&#8217;s website a few days after. About Evogene: Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) is a computational biology company leveraging big &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-fourth-quarter-2024-financial-results-release\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Evogene Schedules Fourth Quarter 2024 Financial Results Release&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-815431","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Evogene Schedules Fourth Quarter 2024 Financial Results Release - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-fourth-quarter-2024-financial-results-release\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Evogene Schedules Fourth Quarter 2024 Financial Results Release - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire Zoom conference call scheduled for March 6, 2025, 9:00 AM ET REHOVOT, Israel, Feb. 20, 2025 \/PRNewswire\/ &#8212;\u00a0Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the fourth quarter of 2024, on Thursday, March 6, 2025. Later that day, Company management will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time). To join the conference, please register in advance: https:\/\/us06web.zoom.us\/webinar\/register\/WN_1cToyoipTfW8X0xtgEqPfw The entire conference will be available online on the company&#8217;s website a few days after. About Evogene: Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) is a computational biology company leveraging big &hellip; Continue reading &quot;Evogene Schedules Fourth Quarter 2024 Financial Results Release&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-fourth-quarter-2024-financial-results-release\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-20T12:23:49+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/mma.prnewswire.com\/media\/1947468\/4576969\/Evogene_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-schedules-fourth-quarter-2024-financial-results-release\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-schedules-fourth-quarter-2024-financial-results-release\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Evogene Schedules Fourth Quarter 2024 Financial Results Release\",\"datePublished\":\"2025-02-20T12:23:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-schedules-fourth-quarter-2024-financial-results-release\\\/\"},\"wordCount\":347,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-schedules-fourth-quarter-2024-financial-results-release\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/mma.prnewswire.com\\\/media\\\/1947468\\\/4576969\\\/Evogene_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-schedules-fourth-quarter-2024-financial-results-release\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-schedules-fourth-quarter-2024-financial-results-release\\\/\",\"name\":\"Evogene Schedules Fourth Quarter 2024 Financial Results Release - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-schedules-fourth-quarter-2024-financial-results-release\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-schedules-fourth-quarter-2024-financial-results-release\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/mma.prnewswire.com\\\/media\\\/1947468\\\/4576969\\\/Evogene_Logo.jpg\",\"datePublished\":\"2025-02-20T12:23:49+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-schedules-fourth-quarter-2024-financial-results-release\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-schedules-fourth-quarter-2024-financial-results-release\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-schedules-fourth-quarter-2024-financial-results-release\\\/#primaryimage\",\"url\":\"http:\\\/\\\/mma.prnewswire.com\\\/media\\\/1947468\\\/4576969\\\/Evogene_Logo.jpg\",\"contentUrl\":\"http:\\\/\\\/mma.prnewswire.com\\\/media\\\/1947468\\\/4576969\\\/Evogene_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-schedules-fourth-quarter-2024-financial-results-release\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Evogene Schedules Fourth Quarter 2024 Financial Results Release\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Evogene Schedules Fourth Quarter 2024 Financial Results Release - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-fourth-quarter-2024-financial-results-release\/","og_locale":"en_US","og_type":"article","og_title":"Evogene Schedules Fourth Quarter 2024 Financial Results Release - Market Newsdesk","og_description":"PR Newswire Zoom conference call scheduled for March 6, 2025, 9:00 AM ET REHOVOT, Israel, Feb. 20, 2025 \/PRNewswire\/ &#8212;\u00a0Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the fourth quarter of 2024, on Thursday, March 6, 2025. Later that day, Company management will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time). To join the conference, please register in advance: https:\/\/us06web.zoom.us\/webinar\/register\/WN_1cToyoipTfW8X0xtgEqPfw The entire conference will be available online on the company&#8217;s website a few days after. About Evogene: Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) is a computational biology company leveraging big &hellip; Continue reading \"Evogene Schedules Fourth Quarter 2024 Financial Results Release\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-fourth-quarter-2024-financial-results-release\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-20T12:23:49+00:00","og_image":[{"url":"http:\/\/mma.prnewswire.com\/media\/1947468\/4576969\/Evogene_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-fourth-quarter-2024-financial-results-release\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-fourth-quarter-2024-financial-results-release\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Evogene Schedules Fourth Quarter 2024 Financial Results Release","datePublished":"2025-02-20T12:23:49+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-fourth-quarter-2024-financial-results-release\/"},"wordCount":347,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-fourth-quarter-2024-financial-results-release\/#primaryimage"},"thumbnailUrl":"http:\/\/mma.prnewswire.com\/media\/1947468\/4576969\/Evogene_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-fourth-quarter-2024-financial-results-release\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-fourth-quarter-2024-financial-results-release\/","name":"Evogene Schedules Fourth Quarter 2024 Financial Results Release - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-fourth-quarter-2024-financial-results-release\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-fourth-quarter-2024-financial-results-release\/#primaryimage"},"thumbnailUrl":"http:\/\/mma.prnewswire.com\/media\/1947468\/4576969\/Evogene_Logo.jpg","datePublished":"2025-02-20T12:23:49+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-fourth-quarter-2024-financial-results-release\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-fourth-quarter-2024-financial-results-release\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-fourth-quarter-2024-financial-results-release\/#primaryimage","url":"http:\/\/mma.prnewswire.com\/media\/1947468\/4576969\/Evogene_Logo.jpg","contentUrl":"http:\/\/mma.prnewswire.com\/media\/1947468\/4576969\/Evogene_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-fourth-quarter-2024-financial-results-release\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Evogene Schedules Fourth Quarter 2024 Financial Results Release"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815431","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=815431"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815431\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=815431"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=815431"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=815431"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}